06185.HK
CanSino Biologics, Inc.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 25.78
−0.46%Leverage
- Debt / equity
- 0.19x
- Net debt / equity
- -0.04x
- Debt / assets
- 0.14x
- Debt / EBITDA
- 21.43x
- Net debt / EBITDA
- -4.56x
Liquidity & coverage
- Current ratio
- 4.23x
- Quick ratio
- 3.70x
- Cash ratio
- 2.32x
- Interest coverage
- -2.84x
- EBITDA / interest
- 2.39x
- Working capital
- HKD 2.9B
Cash & dividend
- FCF / debt
- -0.07x
- Cash flow / debt
- 0.10x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026